Exela Pharma Sciences
Manufacturing · North Carolina, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
1245 Blowing Rock Blvd, Lenoir, North Ca...Phone Number
(703) 964-7884Website
www.exelapharma.comRevenue
$67.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
4
1
1
1
1
About Exela Pharma Sciences
Exela Pharma Sciences is an award-winning integrated specialty pharmaceutical company that develops and manufactures proprietary and generic sterile injectable products. Founded in 2005 and based in Lenoir, North Carolina, the company focuses on addressing the unique needs of healthcare providers while improving patient experiences and alleviating drug shortages. Exela operates two business units: Finished Drug Products and Contract Development and Manufacturing Organization (CDMO), leveraging significant cGMP sterile manufacturing capacity. Their commitment to quality and reliability has established them as a trusted partner in the pharmaceutical industry.Explore more
Exela Pharma Sciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Exela Pharma Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Exela Pharma Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Exela Pharma Sciences
Check if Exela Pharma Sciences has recently received funding, and reach out quickly before it becomes old news!
Click to see if Exela Pharma Sciences had a recent Job posting/layoffs
Product Launch: Get notified when Exela Pharma Sciences launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Exela Pharma Sciences recently announced quarterly report
Funding: Get notified immidiatlly once Exela Pharma Sciences has new funding data
Website visits: Recent activity has been detected on your website
Check out if Exela Pharma Sciences is spiking on competitors!
Recommended Actions
Find VP level buyers at Exela Pharma Sciences
Find 2 more new buyers
Compare Similar Companies to Exela Pharma Sciences
Compare insights from companies similar to Exela Pharma Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Exela Pharma Sciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Exela Pharma Sciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Exela Pharma Sciences.
Exela Pharma Sciences financials insights
Gather financial insights about Exela Pharma Sciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$2M
Exela Pharma Sciences Tech Stack
A closer look at the technologies used by Exela Pharma Sciences
Most Recent Scoops
Open Position
Hiring Plans
Exela Pharma Sciences has more open roles in Information Technology than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Exela Pharma Sciences has more open roles in Operations than it has had at any time in the past 12 months. Areas of expertise include: Organizing Meetings, Lean Manufacturing, Organizational Structure, Process Improvement, Current Good Manufacturing Practices (cGMPS), Good Manufacturing Practices, and Production Schedule.
Hiring Plans
Hiring Plans
Exela Pharma Sciences is hiring in Human Resources for the first time in 12 months.
Hiring Plans
Hiring Plans
Hiring Plans
Exela Pharma Sciences News & Media
Premier Inc. and 11 Leading Health Systems Invest in Exela Pharma Sciences to Secure and Support U.S.- Based Drug Supply and Manufacturing
CHARLOTTE, N.C.,--(BUSINESS WIRE)--Premier and 11 leading health systems invest in Exela Pharma Sciences to secure and support U.S.-based drug supply and manufacturing.Caplin Steriles secures USFDA nod for Neostigmine Methylsulfate Injection
Chennai: Caplin Steriles Limited, a subsidiary company of Caplin Point Laboratories Limited, has been granted final approval from the United States Food and Drug Administration (USFDA) for its...Exela Technologies Launches the IntelliScan Raptor, a Versatile High-Speed Enterprise Scanning Platform with a Unique Compact Design
IRVING, Texas, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Exela Technologies, Inc. (“Exela” or “the Company”) (NASDAQ: XELA), a global business process automation (BPA) leader, today announced the launch of the IntelliScan Raptor scanner, which is the latest addition to Exela’s line of industry-leading document digitization and data extraction platforms.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Exela Pharma Sciences
Sign Up For FreeTo access detailed company insights
Exela Pharma Sciences is an award-winning integrated specialty pharmaceutical company that develops and manufactures proprietary and generic sterile injectable products. Founded in 2005 and based in Lenoir, North Carolina, the company focuses on addressing the unique needs of healthcare providers while improving patient experiences and alleviating... Read More
